ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Increase Cancer Center Grants More Than R01s, SPOREs, Report Tells NCI

February 28, 2003

CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development

August 24, 1979

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

April 27, 2012

ACCR Considers Foriend Membership, Meeting With ASCO

June 14, 1991